Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04954183 · ClinicalTrials.gov registry record
Development of an EEG Diagnostic for Alzheimer's Disease
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 29
- Enrollment target
NCT04954183: Completed study, sponsored by Mayo Clinic.
NCT04954183 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 29 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04954183 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 29 participants
- Enrollment target
Study Summary
The purpose of this research is to collect and compare electroencephalogram data from all stages of Alzheimer's disease from preclinical through severe dementia.
Primary Outcome
Number of EEG data on individuals at all stages of Alzheimer's disease from preclinical through severe dementia.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2021-10-01 |
| Est. Completion | 2025-07-24 |
What the finished NCT04954183 record still lists
NCT04954183 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 29 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT04954183 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04954183 about?
NCT04954183 is a clinical study titled "Development of an EEG Diagnostic for Alzheimer's Disease". The purpose of this research is to collect and compare electroencephalogram data from all stages of Alzheimer's disease from preclinical through severe dementia.
What is the current status of trial NCT04954183?
This trial is currently completed. The enrollment target is 29 participants. The study started on 2021-10-01. Estimated completion is 2025-07-24.
Who is sponsoring clinical trial NCT04954183?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02429557 · 29 participants · Phase 1
Hemodynamic Mechanisms of Abdominal Compression in the Treatment of Orthostatic Hypotension in Autonomic Failure
- NCT02568878 · 29 participants · Phase 3
Creatine for Depressed Male and Female Methamphetamine Users
- NCT03014401 · 29 participants · NA
The Effect of Adipose-Derived Stem Cells for Knee Osteoarthritis
- NCT03128996 · 29 participants · Phase 1
Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI